The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countries.

Howard N, Mounier-Jack S, Gallagher KE, Kabakama S, Griffiths UK, Feletto M, LaMontagne DS, Burchett HE, Watson-Jones D.

Hum Vaccin Immunother 2016;12:2475-7.

PMID:27159786

PMCID:PMC5027708

DOI:10.1080/21645515.2016.1178433

Related citation